Ranbaxy Laboratories Limited

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Ranbaxy Laboratories Limited sits in the top decile of US sponsors by registered trial count (#407 of 15,751 sponsors by registered trial count).

44 total trials none currently recruiting 44 completed early-phase tilt top decile by trial count

Ranbaxy Laboratories Limited: 44 sponsored US clinical trials, none currently recruiting.

Ranbaxy Laboratories Limited sponsors 44 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 44 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 9 trials.

Top-decile sponsor footprint

Ranbaxy Laboratories Limited ranks in the top decile of sponsors by registered trial count (#407 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

44 total, page 1 of 1

COMPLETED Phase 1

A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions

NCT01499771

COMPLETED Phase 1

A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.

NCT01499758

COMPLETED Phase 1

Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions

NCT01276080

COMPLETED Phase 1

Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions

NCT01276067

COMPLETED NA

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

NCT00778427

COMPLETED NA

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

NCT00778466

COMPLETED NA

Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions

NCT00778180

COMPLETED NA

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions

NCT00778973

COMPLETED NA

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

NCT00779051

COMPLETED NA

Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions

NCT00779441

COMPLETED NA

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions

NCT00779350

COMPLETED NA

Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

NCT00775905

COMPLETED NA

Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

NCT00775151

COMPLETED NA

Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions

NCT00775177

COMPLETED NA

Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions

NCT00775918

COMPLETED NA

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

NCT00775580

COMPLETED NA

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

NCT00776022

COMPLETED NA

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

NCT00778115

COMPLETED NA

Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions

NCT01222923

COMPLETED NA

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

NCT00778674

COMPLETED NA

Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions

NCT01222975

COMPLETED NA

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

NCT00776139

COMPLETED NA

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions

NCT00779233

COMPLETED NA

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

NCT00778726

COMPLETED NA

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions

NCT00778791

COMPLETED NA

Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

NCT00778141

COMPLETED NA

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

NCT00775996

COMPLETED NA

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

NCT00778024

COMPLETED NA

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

NCT00776620

COMPLETED NA

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

NCT00776490

COMPLETED NA

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

NCT00777972

COMPLETED NA

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

NCT00778713

COMPLETED NA

Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.

NCT00774644

COMPLETED NA

Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

NCT00774696

COMPLETED NA

Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions

NCT00777413

COMPLETED NA

Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

NCT00776334

COMPLETED NA

Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions

NCT00776542

COMPLETED NA

Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

NCT00776672

COMPLETED NA

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions

NCT00778284

COMPLETED NA

Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions

NCT00778050

COMPLETED NA

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions

NCT00778661

COMPLETED NA

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

NCT00778232

COMPLETED NA

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions

NCT00778401

COMPLETED NA

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

NCT00775359

Phase Distribution

PhaseTrial count
Phase 1 4

Therapeutic Areas

How the Ranbaxy Laboratories Limited early-phase archive is shaped

44 indexed studies, none listed as recruiting (0% open); 44 completed (100%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Healthy (9 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.